Is Epirus Biopharmaceuticals Inc (EPRS) A Good Stock To Buy?

However, there was a specific group of hedgies who sold off their full holdings by the end of the third quarter. It’s worth mentioning that Ken Griffin’s Citadel Investment Group dropped the biggest position of all the hedgies watched by Insider Monkey, worth close to $0.2 million in call options.

Let’s check out hedge fund activity in other stocks similar to Epirus Biopharmaceuticals Inc (NASDAQ:EPRS). These stocks are Vermillion, Inc. (NASDAQ:VRML), Digital Turbine Inc (NASDAQ:APPS), Ocean Shore Holding Co (NASDAQ:OSHC), and FinTech Acquisition Corp. (NASDAQ:FNTCU). This group of stocks’ market caps are closest to EPRS’s market cap.

As you can see these stocks had an average of 6 hedge funds with bullish positions and the average amount invested in these stocks was $14 million, compared to $32 million in EPRS’s case. Digital Turbine Inc (NASDAQ:APPS) is the most popular stock in this table, while Vermillion, Inc. (NASDAQ:VRML) is the least popular one with only 4 bullish hedge fund positions. Compared to these stocks Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.